¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transition state inhibitor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® vegetative state ÇÑ±Û ½Ä¹°»óÅÂ
¼³¸í   
  ÀÚÀ²½Å°æ°è´Â È°µ¿Çϰí ÀÖÀ¸³ª ¼öÀǿÀÌ ÀüÇô ºÒ´ÉÇÑ »óŸ¦ ¸»ÇÑ´Ù. µû¶ó¼­ È£Èí, ½É¹ÚÀº Áö¼ÓÇϰí ÀÖÀ¸³ª ÀǽÄÀûÀΠȰµ¿À» ÀÏÀ¸Å°´Â ÀÏÀº ÇÒ ¼ö ¾ø´Ù. ¿øÀÎÀº µÎºÎ¿Ü»ó-ôÃß¼Õ»ó-³úÇ÷°ü¼Õ»ó-³úô¼öÁ¾¾ç-Áßµ¶ µî ¿©·¯ °¡Áö°¡ ÀÖÁö¸¸, °¡Àå ¸¹Àº °ÍÀº ±³Åë»ç°í µî¿¡ ÀÇÇÑ ¸Ó¸®¿Ü»óÀÌ´Ù. ´ë³úÀǠǥÃþºÎ´Â ´ë³ú°ÑÁúÀ̶ó Çϴµ¥, ÀÌ °÷¿¡´Â ¹é ¼ö ½Ê¾ïÀÇ ½Å°æ¼¼Æ÷°¡ ¸ð¿© À־ ¿îµ¿-°¨°¢-ÀǽĠµîÀÇ ÀÛ¿ëÀ» ´ã´çÇϰí ÀÖ´Ù. ÀÌ ´ë³ú°ÑÁúÀÇ ¼Õ»óÀ» ÀÔÀ¸¸é ¿îµ¿±â´ÉÀ̳ª ÀǽÄÀÌ Á¤ÁöµÇ°í, ³úÁٱⰡ ´ã´çÇϴ ȣÈí±â´É-¼ÒÈ­±â´É-½ÉÀå¹Úµ¿±â´É ¹Û¿¡ ÇÏÁö ¸øÇϰԠµÈ´Ù.
¿µ¹® persistent vegetative state ÇÑ±Û Áö¼Ó½Ä¹°»óÅÂ
¼³¸í   
  ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼­ ÀϾ´Â °¢¼º»óÅ¿¡ À־ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ­, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Æ¯Â¡À¸·Î Çϸç, ³úÆÄ´Â Æòźȭ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • demographic transition
    Àα¸ÇÐÀûÀÌÇà
  • phase transition
    À§»óÀüÀÌ
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • angiotensin converting enzyme inhibitor
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • inhibitor
    1. ¾ïÁ¦Á¦ 2. ¾ïÁ¦ÀÎÀÚ
  • mitotic inhibitor
    À¯»çºÐ¿­¾ïÁ¦Á¦
  • metabolic inhibitor
    ´ë»ç¾ïÁ¦Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦Á¦
  • selective serotonin reabsorption inhibitor
    ¼±Åü¼·ÎÅä´ÑÀçÈí¼ö¾ïÁ¦Á¦
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • state
    »óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • ordinary state
    Á¤»ó»óÅÂ
  • panic state
    °øÈ²»óÅÂ
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
  • postprandial state
    ½ÄÈÄ»óÅÂ
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
  • saturation state
    Æ÷È­»óÅÂ
  • steady state
    Ç×Á¤»óÅÂ
  • vegetative state
    ½Ä¹°»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • demographic transition
    Àα¸ÇÐÀûÀÌÇà
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • phase transition
    À§»óÀüÀÌ
  • role transition
    ¿ªÇÒÀüȯ
  • transition ray
    °úµµ¼±, ÀÌÇ༱
  • transition
    º¯ÀÌ, ÀÌÇà, õÀÌ
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • inhibitor
    ¾ïÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • age of transition
    °úµµ±â.
  • phase transition
    À§»óÀüÀÌ.
  • range of transition
    Àüȯ¹üÀ§.
  • ACEI : angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ï®ü½ý£áÈåäð¤ð¥).
  • CAI=£¾carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼ÒÀúÇØ¾à, ź»êÅ»¼öÈ¿¼ÒÀúÇØ¹°Áú.
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î»êÈ­È¿¼Ò ¾ïÁ¦Á¦.
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î »êÈ­È¿¼Ò ÀúÇØÁ¦.
  • MAO inhibitor(MAOI)
    ´Ü°¡¾Æ¹Î»êÈ­È¿¼Ò¾ïÁ¦Á¦
  • RIMA, see reversible inhibitor of MAO-A
    °¡¿ªÀû ´Ü°¡¾Æ¹Î-A »êÈ­È¿¼Ò¾ïÁ¦Á¦
  • acetylcholinesterase inhibitor
    ¾Æ¼¼Æ®Äݸ°¿¡½ºÅÍ·¹À̽º<¿¡½ºÅ×¶óÁ¦> ¾ïÁ¦Á¦.
  • activated protein C inhibitor
    Ȱ¼ºÈ­´Ü¹éÁú C ¾ïÁ¦Á¦
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • growth inhibitor
    ¼ºÀå<¹ßÀ°>¾ïÁ¦¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dream state, dream-like state, dreamy state
    ¸ù·Õ»óÅÂ(ÙÔÖèßÒ÷¾).
  • age of transition
    °úµµ±â.
  • demographic transition
    Àα¸ÇÐÀû ÀÌÇà (ÊÙËöÌ´).
  • phase transition
    À§»óÀüÀÌ.
  • range of transition
    Àüȯ¹üÀ§.
  • role transition(s)
    ¿ªÇÒÀüȯ
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀüȯ±âÀå¾Ö(º´)
  • transition
    õÀÌ.
  • transition element
    ÀüÀÌ¿ø¼Ò(ï®ì¹êªáÈ).
  • transition point
    ÀüÀÌÁ¡(ËøËöËø).
  • transition probability
    ÃßÀÌÈ®·ü(̧ËöÌ·Ëô).
  • transition ray
    °úµµ¼±
  • transition ray
    ÀÌÇ༱
  • transition temperature
    ÀüÀ̿µµ(ï®ì¹è®öô).
  • acetylcholinesterase inhibitor
    ¾Æ¼¼Æ®Äݸ°¿¡½ºÅÍ·¹À̽º<¿¡½ºÅ×¶óÁ¦> ¾ïÁ¦Á¦.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Crypt state
    ¿ò»óÅÂ
    [¿¾ ¿ë¾î] Àº¿Í»óÅÂ
  • Proliferative state
    Áõ½Ä»óÅÂ
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Vestigial state
    ÈçÀû»óÅÂ
    [¿¾ ¿ë¾î] ÈçÀû»óÅÂ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transition state inhibitor
    õÀÌ»óÅ ÀúÇØÁ¦(ôÃì¹ßÒ÷¾îÁúªð¥)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transition state
    õÀÌ»óÅÂ(ôÃì¹ßÒ÷¾)
  • transition state theory
    õÀÌ »óÅ ÀÌ·Ð(ôÃì¹ßÒ÷¾×âÖå)
  • helix-coil transition
    ³ª¼±(Õ¢àÁ)-ÄÚÀÏ ÃµÀÌ(ôÃì¹)
  • inside out transition
    ³»¿ÜÀüµµ õÀÌ(Ò®èâï´ÓîôÃì¹)
  • isomeric transition
    ¾ÆÀ̼ҸÓÀüÀÌ(ï®ì¹)
  • magnetic transition moment
    ÀÚ±âõÀ§(í¸ÐïôÃêÈ) ¸ð¸àÆ®
  • radiationless transition
    ¹«¹æ»ç¼± ÀüÀÌ(ÙíÛ¯ÞÒàÊï®ì¹)
  • rotational transition
    ȸÀü ÀüÀÌ(üÞï®ï®ì¹)
  • transition
    "õÀÌ (ôÃì¹), ¿°±âÀüȯ (ç¤Ðñï®üµ)"
  • transition dipole moment
    õÀÌ ½Ö±ØÀÚ(ôÃì¹äªÐ¿í­)¸ð¸àÆ®
  • transition element
    õÀÌ¿ø¼Ò(ôÃì¹êªáÈ)
  • transition temperature
    õÀ̿µµ(ôÃì¹è®Óø)
  • vibrational transition
    Áøµ¿ õÀÌ(òÉÔÑôÃì¹)
  • vibronic transition
    Áøµ¿ õÀÌ(òÉÔÑôÃì¹)
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦Á¦, ¾ïÁ¦¹°Áú, ¾ïÁ¦ÀÎÀÚ, ¾ïÁ¦½Å°æ, ¾ïÁ¦À¯ÀüÀÚ, ¾ïÁ¦¾à
  • transition ray
    ÀÌÇ༱
  • CE FAST [=contrast enhanced fast acquisition in the steady state]
    Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°­°í¼Óȹµæ
  • DESS [=double echo in the steady state]
    Ç×Á¤»óÅÂÀÇ ÀÌÁß¿¡ÄÚ
  • excitation state
    ¿©±â»óÅÂ, ÈïºÐ»óÅÂ
  • fast imaging with steady state precession [=FISP]
    Ç×Á¤»óż¼Â÷¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó¿µ»ó
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • Fourier acquisition in the steady state [=FAST]
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ
  • partial saturation state
    ºÎºÐÆ÷È­»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
  • saturation state
    Æ÷È­»óÅÂ
  • SSFP [=steady state free precession]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
  • steady state
    Ç×Á¤»óÅÂ
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • steady state free precession [=SSFP]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BPTI basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
LES Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru...
IDS iduronate sulfatase; immune deficiency state; inhibitor of DNA synthesis; integrated delivery system...
ESI elastase-specific inhibitor; enzyme substrate inhibitor; epidural steroid injection
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TS transition state
ACE inhibitor angiotensin converting enzyme inhibitor
EMT Epithelial-mesenchymal transition
MBT Mid-Blastula-Transition
MPT Mitochondrial Permeability Transition
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • demographic transition
    Àα¸ÇÐÀû ÀÌÇà
  • reconstructive transition
    Àç°Ç ÀüÀÌ
    ÃÖ±ÙÁ¢ ¹èÀ§´Â º¯ÇÏÁö ¾ÊÁö¸¸, ´ÙÀ½ÀÇ ÀÎÁ¢¿øÀÚ¸¦ ÇöÀúÇÏ°Ô À̵¿½ÃŰ°Å³ª °áÇÕÀ» Àü´ÜÇÔ¿¡ ÀÇÇØ »õ·Î¿î ±¸Á¶¸¦ ¸¸µå´Â ÀüÀÌ.
  • transition
    º¯ÀÌ, ÀüÀÌ, ÀüÀÌÇà
    ÇϳªÀÇ »óÅ¿¡¼­ Á¾·ù°¡ ´Ù¸¥ »óÅ·Πº¯È­ÇÏ´Â °Í. ¿ø¼Ò, ºÐÀÚ µîÀÇ ÀüÀÌ.
  • transition line
    º¯È¯¼±
  • transition ray
    ÀÌÇà ¼±
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • C1-esterase inhibitor
    C1-esterase ¾ïÁ¦ ¹°Áú
  • cell wall inhibitor
    ¼¼Æ÷ º® ÇÕ¼º ¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°í ÀÎÀÚ ¾ïÁ¦Á¦
  • collagenase inhibitor
    Äݶó°Ô³ªÁ¦ ¾ïÁ¦ ¹°Áú
  • cyclooxygenase inhibitor
    »çÀÌŬ·Î¿Á½ÃÁö³×ÀÌÁî ¾ïÁ¦Àç
  • dopa decarboxylase inhibitor
    µµÆÄ µ¥Ä«¸£º¹½Ç·¹À̽º ¾ïÁ¦ÀÚ
  • lipoxygenase inhibitor
    ¸®ÆÜ½ÃÁö³×À̽º ¾ïÁ¦Á¦
  • metabolic inhibitor
    ´ë»ç ÀúÇØÁ¦, ´ë»ç ¾ïÁ¦Á¦
  • polymerization inhibitor
    ÁßÇÕ ±ÝÁöÁ¦
    ÁßÇÕ ¹ÝÀÀÀ» ¹æÇØÇϱ⵵ Çϰí, ÁßÁöÇÒ ¼ö ÀÖ´Â ¹°Áú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
transition state The activated state of a molecule that has partly undergone a chemicalreaction.
(09 Oct 1997)
transition state intermediate In a chemical reaction, an unstable and high-energy configuration assumed by reactants on the way to making products. Enzymes are thought to bindand stabilise the transition state, thus lowering the energy of activation needed to drive the reaction to completion.
(09 Oct 1997)
cervicothoracic transition The junction between the last cervical vertebra and first thoracic vertebra.
(05 Mar 2000)
health transition Demographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterised by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition.
(12 Dec 1998)
helix-coil transition <molecular biology> A change in the structure of a nucleic acid or protein molecule from a highly ordered, complex structure to a random, chaotic structure. Also means that the protein or nucleic acid becomes denatured.
(09 Oct 1997)
isomeric transition The transition of a nuclear isomer to a lower quantum state; e.g., 131mXe &rarr; 131Xe + g.
(05 Mar 2000)
transition 1. Passage from one place or state to another; charge; as, the transition of the weather from hot to cold. "There is no death, what seems so is transition." (Longfellow)
2. A direct or indirect passing from one key to another; a modulation.
3. A passing from one subject to another. "[He] with transition sweet, new speech resumes." (Milton)
4. <biology> Change from one form to another.
This word is sometimes pronounced; but according to Walker, Smart, and most other authorities, the customary and preferable pronunciation is, although this latter mode violates analogy. Other authorities say .
<geology> Transition rocks, a term formerly applied to the lowest uncrystalline stratified rocks (graywacke) supposed to contain no fossils, and so called because thought to have been formed when the earth was passing from an uninhabitable to a habitable state.
Origin: L. Transitio: cf. F. Transition. See Transient.
Source: Websters Dictionary
(01 Mar 1998)
transition electron An electron that moves from one energy level to another to fill a vacancy in a shell, with the emission of characteristic radiation.
(05 Mar 2000)
transition mutation A point mutation involving substitution of one base-pair for another, i.e., replacement of one purine for another and of one pyrimidine for another pyrimidine without change in the purine-pyrimidine orientation.
(05 Mar 2000)
transition probability model A model to account for the apparently random variation in cell cycle time between individual animal tissue cells in culture that postulates that transition from G1 to s phase is probabilistic. Contrasts with hypotheses that require the accumulation of critical levels of particular proteins.
(18 Nov 1997)
transition protein <molecular biology> In spermatogenesis, group of proteins that displace histones from nuclear DNA and that are in turn displaced by protamines to produce the transcriptionally inactive nuclear DNA characteristic of the sperm nucleus.
(18 Nov 1997)
transition temperature <chemistry> The temperature at which there is a transition in the organisation of, for example: the phospholipids of a membrane where the transition temperature marks the shift from fluid to more crystalline. Usually determined by using an Arrhenius plot of activity against the reciprocal of absolute temperature, the transition temperature being that temperature at which there is an abrupt change in the slope of the plot. In membranes such phase transitions tend to be inhibited by the presence of cholesterol.
(18 Nov 1997)
a1-trypsin inhibitor A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin.
Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor.
(05 Mar 2000)
ACE inhibitor <pharmacology> A group of antihypertensive medications that work by inhibiting an enzyme (angiotensin-converting enzyme) that is important in the regulation of blood pressure.
Studies have also indicated that it may help prevent or slow the progression of kidney disease in patients with diabetes.
Examples include: captopril, ramipril, enalapril, losartan potassium, bepridil and lisinopril.
(12 Mar 1998)
aldose reductase inhibitor <pharmacology> A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes.
Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy.
Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦ÀÚ(¹°);¹ÝÀÀ¾ïÁ¦Á¦
  • transition
    º¯È­; °úµµ±â
  • demographic transition
    Àα¸ÇÐÀû ÃßÀÌ(Ãâ»ý·ü,»ç¸Á·üÀÇ ÁÖµÈ º¯È­)
  • transition
    º¯Ãµ;º¯ÀÌ;°úµµ±â;(ÀϽÃÀû) ÀüÁ¶
  • state
    »óÅÂ,±¹°¡,ÁÖ,½ÅºÐ,ÁöÀ§
  • state rights
    ÁÖÀÇ ±Ç¸®
  • state' attorney
    ÁÖ´ëÇ¥ÀÇ º¯È£»ç
  • state's attorney
    ÁÖ´ëÇ¥ÀÇ º¯È£»ç
  • Badger State
    ¹Ì±¹ÀÇ ÁÖ
  • Bear State
    arkansasÁÖÀÇ µý À̸§
  • Beehive State
    Utah ÁÖÀÇ µý À̸§
  • Centennial State
    ¹Ì±¹ ColoradoÁÖÀÇ ¼ÓĪ
  • Coal State
    PennsylvaniaÁÖÀÇ ¼ÓĪ
  • Constitution State
    ¹Ì±¹ ConnecticutÁÖÀÇ ¼ÓĪ
  • Cornhusker State
    NebraskaÁÖÀÇ ¼ÓĪ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á